TrialBlood cancer journal2021

Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma.

Ulrich Dührsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.